NFKB1 and schizophrenia: We then assessed the extent to which alterations in NF-κB pathway member mRNAs in the blood: 1) occur in all patients or are unique to patients with inflammation; and 2) are schizophrenia-specific or also occur in non-schizophrenic controls with active inflammation (and thus reflect high inflammatory status regardless of diagnosis).